SaaS Metrics
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting patient accessibility. We present an in vivo engineering strategy using targeted lipid nanoparticles (tLNPs) for messenger RNA delivery to specific T cell subsets. These tLNPs reprogrammed CD8
+
T cells in both healthy donor and autoimmune patient samples, and in vivo dosing resulted in tumor control in humanized mice and B cell depletion in cynomolgus monkeys. In cynomolgus monkeys, the reconstituted B cells after depletion were predominantly naïve, suggesting an immune system reset. By eliminating the requirements for complex ex vivo manufacturing, this tLNP platform holds the potential to make CAR T cell therapies more accessible and applicable across additional clinical indications.
Academic Publication In vivo CAR T cell generation to treat cancer and autoimmune disease
Research Abstract & Technology Focus
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Investigating the impact of combustible and electronic cigarettes on clonal hematopoiesis
Self-renewing hematopoietic stem cells (HSCs) produce billions of blood cells a day to maintain peripheral blood and immune cells in circulation. Inflammation can alter the balance of steady-state ...
Regulatory mechanisms of PD-1/PD-L1 in cancers
AbstractImmune evasion contributes to cancer growth and progression. Cancer cells have the ability to activate different immune checkpoint pathways that harbor immunosuppressive functions. The prog...
In vivo site-specific engineering to reprogram T cells
Stable and cell-specific transgene expression can be achieved through in vivo site-specific integration of large DNA payloads using a two-vector system of enveloped delivery vehicles and adeno-asso...
Targeting of TAMs: can we be more clever than cancer cells?
АbstractWith increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new antican...
Cancer stem cell mimicry for immune evasion and therapeutic resistance
No description provided.
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'In vivo CAR T cell generation to treat cancer and autoimmune disease'?
This literature focuses on: Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity for lymphodepleting chemotherapy, restricting pa...
Are there open-source GitHub repositories related to In vivo CAR T cell generation to treat cancer and autoimmune disease?
Yes, open-source projects like PKU-YuanGroup/Helios (Helios: Real Real-Time Long Video Generation Model) are actively building upon these concepts.
Which startups are commercializing the technology behind In vivo CAR T cell generation to treat cancer and autoimmune disease?
Products like Nano Banana 2 are bringing this to market. Their focus is: Google's latest AI image generation model .
What other academic literature is closely related to 'In vivo CAR T cell generation to treat cancer and autoimmune disease'?
Yes, highly correlated activity was mapped. An entry titled 'Investigating the impact of combustible and electronic cigarettes on clonal hematopoiesis' discusses this: Self-renewing hematopoietic stem cells (HSCs) produce billions of blood cells a day to maintain peripheral blood and immune cells in circulation. I...
Are there commercial applications of 'In vivo CAR T cell generation to treat cancer and autoimmune disease' in market news publications?
Yes, highly correlated activity was mapped. An entry titled 'In vivo site-specific engineering to reprogram T cells' discusses this: Stable and cell-specific transgene expression can be achieved through in vivo site-specific integration of large DNA payloads using a two-vector sy...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
GitHubPKU-YuanGroup/Helios
-
GitHubsantifer/career-ops
-
Product HuntNano Banana 2
-
Product HuntmvntSTUDIO